FREE SHIPPING over $40
OVER 9000 FIVE-STAR REVIEWS
5% OFF ALL SUBSCRIPTIONS
100% HAPPINESS GUARANTEE
Analyze Diet
0
Home / Equine Research Bank / Am J Physiol Endocrinol Metab / Equine hyperinsulinemia: investigation of the enteroinsular ...
American journal of physiology. Endocrinology and metabolism2015; 310(1); E61-E72; doi: 10.1152/ajpendo.00362.2015

Equine hyperinsulinemia: investigation of the enteroinsular axis during insulin dysregulation.

Abstract: Compared with some other species, insulin dysregulation in equids is poorly understood. However, hyperinsulinemia causes laminitis, a significant and often lethal disease affecting the pedal bone/hoof wall attachment site. Until recently, hyperinsulinemia has been considered a counterregulatory response to insulin resistance (IR), but there is growing evidence to support a gastrointestinal etiology. Incretin hormones released from the proximal intestine, glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic peptide, augment insulin secretion in several species but require investigation in horses. This study investigated peripheral and gut-derived factors impacting insulin secretion by comparing the response to intravenous (iv) and oral d-glucose. Oral and iv tests were performed in 22 ponies previously shown to be insulin dysregulated, of which only 15 were classified as IR (iv test). In a more detailed study, nine different ponies received four treatments: d-glucose orally, d-glucose iv, oats, and commercial grain mix. Insulin, glucose, and incretin concentrations were measured before and after each treatment. All nine ponies showed similar iv responses, but five were markedly hyperresponsive to oral d-glucose and four were not. Insulin responsiveness to oral d-glucose was strongly associated with blood glucose concentrations and oral glucose bioavailability, presumably driven by glucose absorption/distribution, as there was no difference in glucose clearance rates. Insulin was also positively associated with the active amide of GLP-1 following d-glucose and grain. This study has confirmed a functional enteroinsular axis in ponies that likely contributes to insulin dysregulation that may predispose them to laminitis. Moreover, iv tests for IR are not reliable predictors of the oral response to dietary nonstructural carbohydrate.
Copyright © 2016 the American Physiological Society.
Get Full Text
Publication Date: 2015-11-03 PubMed ID: 26530154DOI: 10.1152/ajpendo.00362.2015Google Scholar: Lookup
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
LinkedInCopy
  • Journal Article
  • Research Support
  • Non-U.S. Gov't

Summary

This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.

The research article studies insulin imbalance in horses, particularly linking digestive system hormone activity to insulin issues and resultant health problems like laminitis. The article suggests that methods for testing insulin resistance in horses require reevaluation considering the observable association between gut-derived factors and insulin regulation.

Insulin Dysregulation in Equines

  • The research mainly focuses on understanding the causes and mechanics of hyperinsulinemia in horses (equids). Hyperinsulinemia, a condition where horses have abnormally high levels of insulin in their blood, can lead to laminitis – a painful and potentially fatal condition affecting horse feet.
  • Previously, hyperinsulinemia in horses was thought to be a response to insulin resistance, but this study presents evidence that significant contributing factors may originate from the gastrointestinal system.
  • Incretin hormones like glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic peptide, which come from the early sections of the intestine, are known to boost insulin secretion in various species. The effect of these hormones on insulin secretion in horses is examined in this study.

Research Methodology and Findings

  • The research involved tests on 22 ponies, previously identified as having insulin dysregulation. Of these, 15 were classified as insulin resistant. The ponies were subjected to two tests, one involving intravenous delivery of glucose and the other oral intake.
  • A more detailed study on nine different ponies compared the insulin, glucose, and incretin levels subsequent to four different treatments: oral d-glucose, intravenous d-glucose, oats, and commercial grain mix.
  • The findings showed important variations in the ponies’ insulin responses between the oral and intravenous glucose administration test. Five of the nine ponies exhibited significant hyperresponsiveness to orally administered d-glucose, while four did not.
  • The insulin response to oral d-glucose was seen as strongly related to blood glucose concentrations and oral glucose bioavailability. Factors like glucose absorption and distribution seem to influence this as glucose clearance rates showed no difference.
  • The active variant of GLP-1 was seen as positively associated with insulin following d-glucose and grain treatment, indicating its role in insulin regulation.

Conclusion and Implication

  • The research concludes that there is a functional ‘enteroinsular axis’ in ponies, suggesting that the digestive system and insulin regulation are closely linked, and contributing to insulin dysregulation that may make them prone to laminitis.
  • One of the significant observations from the research is the unreliability of intravenous tests for predicting the oral response to dietary carbohydrates in the body. This implication calls for a review and possible revision of methods for diagnosing insulin resistance in horses.

Cite This Article

APA
de Laat MA, McGree JM, Sillence MN. (2015). Equine hyperinsulinemia: investigation of the enteroinsular axis during insulin dysregulation. Am J Physiol Endocrinol Metab, 310(1), E61-E72. https://doi.org/10.1152/ajpendo.00362.2015

Publication

American journal of physiology. Endocrinology and metabolism
ISSN: 1522-1555
NlmUniqueID: 100901226
Country: United States
Language: English
Volume: 310
Issue: 1
Pages: E61-E72

Researcher Affiliations

de Laat, M A
  • Science and Engineering Faculty, Queensland University of Technology, Brisbane, Queensland, Australia melody.delaat@qut.edu.au.
McGree, J M
  • Science and Engineering Faculty, Queensland University of Technology, Brisbane, Queensland, Australia.
Sillence, M N
  • Science and Engineering Faculty, Queensland University of Technology, Brisbane, Queensland, Australia.

MeSH Terms

  • Animal Feed
  • Animals
  • Diet
  • Dietary Carbohydrates / pharmacology
  • Enteroendocrine Cells / metabolism
  • Gastrointestinal Tract / drug effects
  • Gastrointestinal Tract / metabolism
  • Glucose Tolerance Test / methods
  • Glucose Tolerance Test / veterinary
  • Horse Diseases / metabolism
  • Horses / metabolism
  • Hyperinsulinism / metabolism
  • Hyperinsulinism / veterinary
  • Incretins / metabolism
  • Insulin / metabolism
  • Insulin Resistance

Citations

This article has been cited 38 times.
  1. Stefaniuk-Szmukier M, Piórkowska K, Ropka-Molik K. Equine Metabolic Syndrome: A Complex Disease Influenced by Multifactorial Genetic Factors.. Genes (Basel) 2023 Jul 27;14(8).
    doi: 10.3390/genes14081544pubmed: 37628596google scholar: lookup
  2. Go YY, Hazard NW, Balasuriya UBR, Chapman AM, Fitton NS, Kenéz Á, Andrews FM. Clinical evaluation of the Immulite® 1000 chemiluminescent immunoassay for measurement of equine serum insulin.. Front Vet Sci 2023;10:1018230.
    doi: 10.3389/fvets.2023.1018230pubmed: 37051514google scholar: lookup
  3. Kellon EM, Gustafson KM. Hypertriglyceridemia in equines with refractory hyperinsulinemia treated with SGLT2 inhibitors.. Open Vet J 2023 Mar;13(3):365-375.
    doi: 10.5455/OVJ.2023.v13.i3.14pubmed: 37026076google scholar: lookup
  4. de Tonnerre DJ, Medina Torres CE, Stefanovski D, Robinson MA, Kemp KL, Bertin FR, van Eps AW. Effect of sirolimus on insulin dynamics in horses.. J Vet Intern Med 2023 Mar;37(2):703-712.
    doi: 10.1111/jvim.16650pubmed: 36840433google scholar: lookup
  5. Warnken T, Schaub C, Delarocque J, Frers F, Feige K, Sonntag J, Reiche DB. Palatability, glycemic, and insulinemic responses to various carbohydrate formulations: Alternatives for the diagnosis of insulin dysregulation in horses?. J Vet Intern Med 2023 Jan;37(1):282-291.
    doi: 10.1111/jvim.16614pubmed: 36625459google scholar: lookup
  6. Loos CMM, McLeod KR, Vanzant ES, Stratton SA, Bohannan AD, Coleman RJ, van Doorn DA, Urschel KL. Differential effect of two dietary protein sources on time course response of muscle anabolic signaling pathways in normal and insulin dysregulated horses.. Front Vet Sci 2022;9:896220.
    doi: 10.3389/fvets.2022.896220pubmed: 35978710google scholar: lookup
  7. Stefanovski D, Robinson MA, Van Eps A. Effect of a GLP-1 mimetic on the insulin response to oral sugar testing in horses.. BMC Vet Res 2022 Jul 29;18(1):294.
    doi: 10.1186/s12917-022-03394-2pubmed: 35906619google scholar: lookup
  8. Loos CMM, Urschel KL, Vanzant ES, Oberhaus EL, Bohannan AD, Klotz JL, McLeod KR. Effects of Bromocriptine on Glucose and Insulin Dynamics in Normal and Insulin Dysregulated Horses.. Front Vet Sci 2022;9:889888.
    doi: 10.3389/fvets.2022.889888pubmed: 35711802google scholar: lookup
  9. Timko KJ, Hostnik LD, Watts MR, Chen C, Bercz A, Toribio RE, Belknap JK, Burns TA. Diagnostic evaluation of insulin and glucose dynamics in light-breed horses receiving dexamethasone.. Can Vet J 2022 Jun;63(6):617-626.
    pubmed: 35656529
  10. Daradics Z, Crecan CM, Rus MA, Morar IA, Mircean MV, Cătoi AF, Cecan AD, Cătoi C. Obesity-Related Metabolic Dysfunction in Dairy Cows and Horses: Comparison to Human Metabolic Syndrome.. Life (Basel) 2021 Dec 16;11(12).
    doi: 10.3390/life11121406pubmed: 34947937google scholar: lookup
  11. D' Fonseca NMM, Beukers M, Wijnberg ID, Navas de Solis C, de Ruijter-Villani M, van Doorn DA, Stout TAE, Roelfsema E. Effect of a long-term high-energy diet on cardiovascular parameters in Shetland pony mares.. J Vet Intern Med 2021 Sep;35(5):2427-2436.
    doi: 10.1111/jvim.16229pubmed: 34350640google scholar: lookup
  12. Delarocque J, Frers F, Huber K, Jung K, Feige K, Warnken T. Metabolic impact of weight variations in Icelandic horses.. PeerJ 2021;9:e10764.
    doi: 10.7717/peerj.10764pubmed: 33575132google scholar: lookup
  13. D'Fonseca NMM, Gibson CME, Hummel I, van Doorn DA, Roelfsema E, Stout TAE, van den Broek J, de Ruijter-Villani M. Overfeeding Extends the Period of Annual Cyclicity but Increases the Risk of Early Embryonic Death in Shetland Pony Mares.. Animals (Basel) 2021 Feb 1;11(2).
    doi: 10.3390/ani11020361pubmed: 33535548google scholar: lookup
  14. Gehlen H, Schwarz B, Bartmann C, Gernhardt J, Stöckle SD. Pituitary Pars Intermedia Dysfunction and Metabolic Syndrome in Donkeys.. Animals (Basel) 2020 Dec 8;10(12).
    doi: 10.3390/ani10122335pubmed: 33302557google scholar: lookup
  15. Wallis N, Raffan E. The Genetic Basis of Obesity and Related Metabolic Diseases in Humans and Companion Animals.. Genes (Basel) 2020 Nov 20;11(11).
    doi: 10.3390/genes11111378pubmed: 33233816google scholar: lookup
  16. Delarocque J, Frers F, Huber K, Feige K, Warnken T. Weight loss is linearly associated with a reduction of the insulin response to an oral glucose test in Icelandic horses.. BMC Vet Res 2020 May 24;16(1):151.
    doi: 10.1186/s12917-020-02356-wpubmed: 32448298google scholar: lookup
  17. d' Fonseca NMM, Gibson CME, van Doorn DA, de Ruijter-Villani M, Stout TAE, Roelfsema E. Effect of long-term overfeeding of a high-energy diet on glucose tolerance in Shetland pony mares.. J Vet Intern Med 2020 May;34(3):1339-1349.
    doi: 10.1111/jvim.15788pubmed: 32374454google scholar: lookup
  18. Spears JW, Lloyd KE, Siciliano P, Pratt-Phillips S, Goertzen EW, McLeod SJ, Moore J, Krafka K, Hyda J, Rounds W. Chromium propionate increases insulin sensitivity in horses following oral and intravenous carbohydrate administration.. J Anim Sci 2020 Apr 1;98(4).
    doi: 10.1093/jas/skaa095pubmed: 32211767google scholar: lookup
  19. Kritchevsky JE, Muir GS, Leschke DHZ, Hodgson JK, Hess EK, Bertin FR. Blood glucose and insulin concentrations after alpha-2-agonists administration in horses with and without insulin dysregulation.. J Vet Intern Med 2020 Mar;34(2):902-908.
    doi: 10.1111/jvim.15747pubmed: 32100334google scholar: lookup
  20. de Laat MA, Spence RJ, Sillence MN, Pollitt CC. An investigation of the equine epidermal growth factor system during hyperinsulinemic laminitis.. PLoS One 2019;14(12):e0225843.
    doi: 10.1371/journal.pone.0225843pubmed: 31805097google scholar: lookup
  21. Rings LM, Swink JM, Dunbar LK, Burns TA, Toribio RE. Enteroinsular axis response to carbohydrates and fasting in healthy newborn foals.. J Vet Intern Med 2019 Nov;33(6):2752-2764.
    doi: 10.1111/jvim.15641pubmed: 31664736google scholar: lookup
  22. Fitzgerald DM, Pollitt CC, Walsh DM, Sillence MN, de Laat MA. The effect of different grazing conditions on the insulin and incretin response to the oral glucose test in ponies.. BMC Vet Res 2019 Oct 16;15(1):345.
    doi: 10.1186/s12917-019-2088-1pubmed: 31619223google scholar: lookup
  23. Horn R, Bertin FR. Evaluation of combined testing to simultaneously diagnose pituitary pars intermedia dysfunction and insulin dysregulation in horses.. J Vet Intern Med 2019 Sep;33(5):2249-2256.
    doi: 10.1111/jvim.15617pubmed: 31498947google scholar: lookup
  24. Hodge E, Kowalski A, Torcivia C, Lindborg S, Stefanovski D, Hart K, Frank N, van Eps A. Effect of thyrotropin-releasing hormone stimulation testing on the oral sugar test in horses when performed as a combined protocol.. J Vet Intern Med 2019 Sep;33(5):2272-2279.
    doi: 10.1111/jvim.15601pubmed: 31432575google scholar: lookup
  25. Moser K, Banse H. Comparison of the glucose and insulin responses of horses to 2 formulations of corn syrup.. Can Vet J 2019 Jun;60(6):637-643.
    pubmed: 31156265
  26. de Laat MA, Reiche DB, Sillence MN, McGree JM. Incidence and risk factors for recurrence of endocrinopathic laminitis in horses.. J Vet Intern Med 2019 May;33(3):1473-1482.
    doi: 10.1111/jvim.15497pubmed: 30972832google scholar: lookup
  27. Meier A, de Laat M, Reiche D, Fitzgerald D, Sillence M. The efficacy and safety of velagliflozin over 16 weeks as a treatment for insulin dysregulation in ponies.. BMC Vet Res 2019 Feb 26;15(1):65.
    doi: 10.1186/s12917-019-1811-2pubmed: 30808423google scholar: lookup
  28. Durham AE, Frank N, McGowan CM, Menzies-Gow NJ, Roelfsema E, Vervuert I, Feige K, Fey K. ECEIM consensus statement on equine metabolic syndrome.. J Vet Intern Med 2019 Mar;33(2):335-349.
    doi: 10.1111/jvim.15423pubmed: 30724412google scholar: lookup
  29. de Laat MA, Sillence MN, Reiche DB. Phenotypic, hormonal, and clinical characteristics of equine endocrinopathic laminitis.. J Vet Intern Med 2019 May;33(3):1456-1463.
    doi: 10.1111/jvim.15419pubmed: 30697823google scholar: lookup
  30. Fitzgerald DM, Walsh DM, Sillence MN, Pollitt CC, de Laat MA. Insulin and incretin responses to grazing in insulin-dysregulated and healthy ponies.. J Vet Intern Med 2019 Jan;33(1):225-232.
    doi: 10.1111/jvim.15363pubmed: 30506731google scholar: lookup
  31. Meier A, Reiche D, de Laat M, Pollitt C, Walsh D, Sillence M. The sodium-glucose co-transporter 2 inhibitor velagliflozin reduces hyperinsulinemia and prevents laminitis in insulin-dysregulated ponies.. PLoS One 2018;13(9):e0203655.
    doi: 10.1371/journal.pone.0203655pubmed: 30212530google scholar: lookup
  32. de Laat MA, Kheder MH, Pollitt CC, Sillence MN. Sweet taste receptor inhibitors: Potential treatment for equine insulin dysregulation.. PLoS One 2018;13(6):e0200070.
    doi: 10.1371/journal.pone.0200070pubmed: 29958298google scholar: lookup
  33. Bertin FR, Ruffin-Taylor D, Stewart AJ. Insulin dysregulation in horses with systemic inflammatory response syndrome.. J Vet Intern Med 2018 Jul;32(4):1420-1427.
    doi: 10.1111/jvim.15138pubmed: 29749643google scholar: lookup
  34. Kheder MH, Bailey SR, Dudley KJ, Sillence MN, de Laat MA. Equine glucagon-like peptide-1 receptor physiology.. PeerJ 2018;6:e4316.
    doi: 10.7717/peerj.4316pubmed: 29404215google scholar: lookup
  35. Lindåse S, Nostell K, Söder J, Bröjer J. Relationship Between β-cell Response and Insulin Sensitivity in Horses based on the Oral Sugar Test and the Euglycemic Hyperinsulinemic Clamp.. J Vet Intern Med 2017 Sep;31(5):1541-1550.
    doi: 10.1111/jvim.14799pubmed: 28796307google scholar: lookup
  36. Frank N, Walsh DM. Repeatability of Oral Sugar Test Results, Glucagon-Like Peptide-1 Measurements, and Serum High-Molecular-Weight Adiponectin Concentrations in Horses.. J Vet Intern Med 2017 Jul;31(4):1178-1187.
    doi: 10.1111/jvim.14725pubmed: 28543933google scholar: lookup
  37. de Laat MA, Hampson BA, Sillence MN, Pollitt CC. Sustained, Low-Intensity Exercise Achieved by a Dynamic Feeding System Decreases Body Fat in Ponies.. J Vet Intern Med 2016 Sep;30(5):1732-1738.
    doi: 10.1111/jvim.14577pubmed: 27639952google scholar: lookup
  38. Banse HE, Holbrook TC, Frank N, McFarlane D. Relationship of skeletal muscle inflammation with obesity and obesity-associated hyperinsulinemia in horses.. Can J Vet Res 2016 Jul;80(3):217-24.
    pubmed: 27408335
Subscribe to our newsletter
Join 99,344 horse owners like you who receive our email updates on horse health and nutrition.